The Clinical Trials Network for European Manufacturers - PowerPoint PPT Presentation

1 / 10
About This Presentation
Title:

The Clinical Trials Network for European Manufacturers

Description:

An innovative molecular imaging program to accelerate clinical trials for investigational therapeutics through improved availability and performance of ... – PowerPoint PPT presentation

Number of Views:84
Avg rating:3.0/5.0
Slides: 11
Provided by: snm95
Category:

less

Transcript and Presenter's Notes

Title: The Clinical Trials Network for European Manufacturers


1
The Clinical Trials Networkfor European
Manufacturers
Sally Schwarz, MS, RPh, BCNP Chair,
Manufacturers Registry Sub-Committee SNM
Clinical Trials Network
2
  • Clinical Trial Challenges Exist
  • Prove the clinical utility of BOTH therapeutic
    and imaging agents
  • Need more use of imaging biomarkers in existing
    therapy trials as surrogate endpoints
  • Need funding of multicenter clinical trials for
    imaging biomarkers
  • Need a framework for timely development
    approval of each

Common needs for pharma and the imaging community
3
  • So specifically, whats not working..?
  • Each company is developing (or re-developing)
    their own biomarkers no standardization
  • Ad hoc application of Molecular Imaging (MI)
    technologies in drug development
  • Lack of consensus on the regulatory
    process/pathway for biomarker development
  • Too much talk, too little action

4
  • An innovative molecular imaging program to
    accelerate clinical trials for investigational
    therapeutics through improved availability and
    performance of investigational imaging
    biomarkers.
  • The Desired Solution

5
  • Early 2008
  • Established A Vision for the Network
  • Facilitate the use of investigational imaging
    biomarkers in multicenter clinical trials of new
    therapeutics
  • Focus on multicenter INDs for imaging biomarkers
    of interest to the therapeutic pharmaceutical
    community
  • Coordinate standardized imaging protocols across
    qualified clinical trial sites via phantom
    utilization
  • Maintain active engagement with the FDA
  • Span drug development, molecular imaging and the
    adherence to good manufacturing practices (GMP)
    of radio-labeled probes

6
  • Phase I Launch August 2008
  • Major Programs Defined
  • Imaging Site Registry
  • Imaging Site Qualification (Phantom Program)
  • Imaging Site Validation Monitoring
  • Manufacturers Registry
  • Safety and Efficacy Reporting Database
  • Multicenter IND Demonstration Project FLT
  • Pathway for Proprietary Biomarkers

7
  • Organization

Committee Chairs Mike Graham Sandy McEwan Peter
Conti Ramsey Badawi Toni Shields George
Segall John Sunderland Sally Schwarz Paul
Christian John Hoffman Denise Harbora
8
  • Global Engagement
  • World wide interest from imagers and manufacturers

9
  • Network Registries (Jun 09)
  • Consistent Growth

10
  • Thank-you for your attention!
Write a Comment
User Comments (0)
About PowerShow.com